PHIO
Phio Pharmaceuticals CorpNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$15.10M
P/E Ratio
—
EPS
$-1.45
Beta
0.81
52W High
$3.48
52W Low
$0.81
50-Day MA
$1.15
200-Day MA
$1.70
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
0.31
PEG Ratio
—
About Phio Pharmaceuticals Corp
Phio Pharmaceuticals Corp. The company is headquartered in Marlborough, Massachusetts.
Fundamentals
| Revenue (TTM) | 0 |
| Gross Profit (TTM) | $-4.62M |
| EBITDA | $-9.22M |
| Operating Margin | 0.00% |
| Return on Equity | -70.00% |
| Return on Assets | -42.30% |
| Revenue/Share (TTM) | $0.00 |
| Book Value | $1.73 |
| Price-to-Book | 0.74 |
| Price-to-Sales (TTM) | 48.01 |
| EV/Revenue | 172.2 |
| EV/EBITDA | 0.61 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $11.62M |
| Float | $11.55M |
| % Insiders | 6.00% |
| % Institutions | 8.20% |
Analyst Ratings
Consensus ($14.00 target)
1
BuyData last updated: 4/9/2026